It catalyzes the biosynthesis of monounsaturated fatty acids that are required for the synthesis of triglycerides, cholesteryl esters and phospholipids. Four mouse isoforms of SCD (SCD1-4) and two human isoforms have been characterized.
INTRODUCTION
Stearoyl-CoA desaturase (SCD) is the rate-limiting enzyme responsible for de novo synthesis of monounsaturated fatty acids from saturated fatty acids (1) (2) (3) (4) . It is an iron-containing enzyme that catalyzes the insertion of the cis double bond at the delta-9 position of fatty acylCoAs in conjunction with cytochrome b 5 reductase, cytochrome b 5 and the cofactor NADH (5-7). The preferred substrates of SCD are palmitoyl (C16:0)-and stearoyl (C18:0)-CoAs which are converted into palmitoleoyl (C16:1)-and oleoyl (C18:1)-CoAs, respectively (8) .
A number of mammalian SCD genes have been cloned and studied. Two SCD genes have been cloned in rats (9) and four (SCD1-4) in mice (10) (11) (12) (13) . In human, two SCD genes (hSCD1 and hSCD5) have been characterized (14, 15) . The mouse isoforms share a high degree of amino acid homology (>70%), but among them, the mouse SCD1 is the best understood. It is comprised of 355 amino acids and is highly regulated by dietary and hormonal factors including glucose (16) , fructose (17) , cholesterol (18) , polyunsaturated fatty acids (19, 20) , insulin (17, 21) and leptin (22) . Research in recent years has unveiled the significant role of SCD1 in lipid metabolism. The products of SCD, palmitoleic and oleic acids, are the most abundant fatty acids found in triglycerides and cholesteryl esters. Significant reduction in tissue triglycerides and cholesteryl esters has been observed in a laboratory mouse model with targeted disruption in the SCD1 gene (SCD1-/-) (23) . It was also found that the SCD1-/-mice have very low levels of triglycerides in the very low density lipoprotein (VLDL) fraction compared to the wild-type counterparts (23) . More interestingly, SCD1 is the major target gene for leptin, and SCD1 deficiency in ob/ob mice results in significant reduction in the production of triglycerides, cholesteryl esters and VLDL (22) . The fact that SCD1-/-mice are resistant to dietand leptin deficiency-induced adiposity makes SCD1 an attractive therapeutic target for the treatment of obesity.
It is obvious that SCD and lipid synthesis are tightly linked. In order to fully understand the role of SCD in lipid metabolism, it is necessary to obtain more complete information on the structure of SCD. However, owing to the intrinsic technical difficulties associated with purification and crystallization of membrane proteins, structural information on membrane-associated desaturases is limited. SCD is a key regulator in membrane fluidity with a rapid turnover rate. Studies have shown that the N-terminal segment of the enzyme contains a sequence responsible for its rapid degradation (24) . It is also known that SCD belongs to a superfamily of membrane-anchored desaturases (5) . Analysis of the primary sequence of the membrane desaturases from a wide range of organisms including mammals, fungi, cyanobacteria, insects and higher-ordered plants indicates conservation of three regions of histidine-box motifs (HxxxxH, HxxHH, and HxxHH). A site-directed mutagenesis study on rat delta-9 desaturase showed that the eight conserved histidine residues are catalytically essential (5) . It was proposed that these His residues serve as ligands for the iron atom contained in these enzymes, thus forming the catalytic site, which is predicted to be located on the cytoplasmic side of the membrane (5) . To date, experimental evidence on the topology of membrane desaturases or enzymes that contain the conserved His-motifs has mainly been derived from studies performed in prokaryotes: acyl-lipid delta-5 desaturase from Bacillus subtilis (25) and membrane-bound alkane hydroxylase of Pseudomonas oleovorans (26). However, no topology analysis has been performed on a mammalian desaturase.
Understanding the structure and orientation of membrane protein will help to reveal the interactions between the substrate and the enzyme as well as its spatial relationship with other proteins present in the vicinity. Based on hydropathy analyses of the sequences of rat and yeast stearoyl-CoA desaturase, Stukey et al. proposed that the structural model of membranebound desaturases consist of four membranespanning domains with the N-and C-termini as well as the catalytic site being oriented towards the cytosolic side of the membrane (27) . However, no experimental evidence is available to date. Therefore, in this current study, we characterize the topology of a mammalian membrane desaturase, the mouse SCD1 isoform. Our data provide evidence that the N-and C-termini of SCD1 are oriented towards the cytosol with four membrane spanning helices separated by two very short hydrophilic loops in the ER lumen and one large hydrophilic loop in the cytosol. Based on this model, the active center of SCD is oriented towards the cytosol. In addition, according to a previous observation that SCD is a thiol enzyme (28), we investigated whether the cysteine residues are important for enzyme activity through mutagenesis studies. Our data show that the cysteines in SCD are not catalytically essential. Preparation of plasmids-The pcDNA3 plasmid expressing SCD1 with the myc epitope tagged to the C-terminus (SCD1 myc-C) was provided by Dr. Travis Knight, Iowa State University. FLAG-GPI8 construct was a gift from Dr. Anant Menon, Cornell University. PCR was employed for the synthesis of other epitope-tagged constructs and SCD1-myc-C was used as the template.
EXPERIMENTAL PROCEDURES

Materials-
To synthesize the SCD1 construct with a HA epitope appended to the N-terminus (N-HA-SCD1), we used a forward primer that contained the EcoRI site, the 27 nucleotides encoding the HA epitope, the first bases of the SCD1 open reading frame (5'-TTGAATTCACCATGTACCCATATGACGTCC  CGGACTACG  CCATGGGGAAGGGAGGTAACC-3') and a  reverse  primer  containing  the  bases  complementary to the final bases of the SCD1 open reading frame and a HindIII site (5'-TTGAAGCTTCAGCTACTCTTGTGACTCCC-3'). The PCR product was then subcloned into the pcDNA 3.1 expression vector. The strategy for constructing plasmids with internal HA epitope and a myc epitope at the C-terminus (93HA-Cmyc , 138HA-C-myc and 241HA-C-myc) was by synthesizing the SCD1 gene as two PCR fragments, fragments A and B, with the amino acid after which an HA tag was inserted being the point of breakage. The 5' end of the PCR fragment A carried an EcoRI site, which was necessary for cloning the gene fragment into the pcDNA3.1 expression vector. The 3' end of PCR fragment A contained the 27 nucleotides that encoded the HA epitope, followed by an XhoI site, which allows the connection of the PCR fragment A to fragment B. The 5' end of PCR fragment B carried an XhoI site, with which it was ligated to fragment A. The 3' end of the fragment B carried the sequence that encoded the myc epitope followed by a HindIII site, which was inserted to facilitate ligation to the expression vector. The sequences of the primers for synthesizing the plasmids containing an internal HA epitope were listed in Table 1 . Figure 1B depicts the construction of the recombinant proteins.
The fragment of SCD1 expressing amino acids 206-272 with the 5' EcoRI and 3' BamHI sites was generated by PCR and was then cloned into pEGFP-C2 vector (forward primer: 5'-ATTGAATTCCTGGTGATGTTCCAGAGG-3', reverse primer: 5'-AATGGATCCTCAGTAGG GGCGATATCCATA -3').
SCD1-myc-C plasmid was used as the template for the generation of the plasmid 233C used in cysteine derivitization study. Site directed mutagenesis was performed using QuikChange® Multi Site-Directed Mutagenesis Kit (Stratagene) according to manufacturer's instruction. All the endogenous cysteines on SCD1 except for the cysteine at amino acid 233 were changed to serine. The sequence of the primers for the mutagenesis were as follow:
The plasmids C92S, C97S, C222S, C233S, and C322S used for the cysteine mutagenesis study were also generated using the QuikChange® Multi Site-Directed Mutagenesis Kit (Stratagene).
Cell Culture and expression of the epitope-tagged SCD1 proteins in HeLa cells-HeLa cells were maintained in high glucose Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% fetal bovine serum (v/v), and 1% penicillin/streptomycin. The cells were incubated at 37ºC in a humidified atmosphere with 5% CO 2 . The transfection of the different constructs into the HeLa cells was performed as described (29) . Briefly, HeLa cells were cultured to 80-100% confluency. The cells were lifted from the plates by the addition of trypsin EDTA and pelleted by centrifugation at 2000 rpm. The cell pellet was then washed by resuspending in 50 mL of cytomix buffer (120 mM KCl, 0.15 mM CaCl 2 , 25 mM HEPES/KOH pH, 7.6, 25 mM EGTA and 25 mM MgCl 2 ) . The cells were then pelleted and 500 μl of cytomix was added to resuspend the cells. The cell suspension was then transferred to an electroporation cuvette. 25 μg of DNA plasmid was added to the cell suspension and the mixture was exposed to a single electric pulse of 300 V with a capacitance of 1000 microfarads using an Biorad pulse system.
The cell mixture was transferred back to a 100 mm culture plate and the cells were incubated in culture medium as described above for 24 or 48 hours as specified before analysis was performed. For indirect immunofluorescence study, cells were plated onto polylysine coated cover slips.
SCD activity assay-The SCD activity assay was performed as described (11 Fluorescence microscopy-About 24 hours post transfection, the cover slips were taken out from the culture plate and washed with PBS three times. The cells were then fixed with 4% paraformaldehyde at room temperature for 10 minutes, followed by an additional three washes with PBS. As for permeabilization of cellular membranes, two conditions were used based on the extent of permeabilization needed. For selective permeabilization of the plasma membrane only, the cells were incubated with a mixture of 3 μg/ml digition, cytomix buffer and 0.3 M sucrose for 15 minutes at 4ºC. For complete permeabilization of cellular membranes including the ER membrane, the cells were treated with 0.3% of Triton X-100 in PBS for 25 minutes at 4ºC. After permeabilization with detergents, the cells were washed with PBS three times and blocked with 10% fetal bovine serum in PBS (v/v) for 1 hour at room temperature. The permeabilized cells were then incubated with antimyc monoclonal antibody at 1:500 dilution or anti-HA monoclonal antibody at 3 μg/ml for 1 hour at room temperature. After incubation with primary antibodies, the cells were washed three times with PBS and incubated with Alexa Fluor 594 goat anti-mouse IgG or Alexa Fluor 488 rabbit anti-rat IgG at a dilution of 1:250 for 1 hour at room temperature. After three more washes with PBS, the cover slips were mounted on microscopy slides with a drop of Vectorshield (Vector Laboratories) added between the slide and the cover slips.
Microscopy was performed to visualize the staining pattern.
For samples containing recombinant proteins fused with GFP, both live cells and fixed cells were analyzed.
Preparation of membrane vesicles -HeLa cells (~1x10
7 cells/ml) were resuspended in buffer A (10 mM Hepes-KOH (pH 7.4), 10 mM KCl, 1.5 mM MgCl 2 , 5 mM sodium EDTA, 5 mM sodium EGTA, 250 mM sucrose) and disrupted using nitrogen cavitation (400 p.s.i. for 15 min) and digested with DNase (2 units/ml) for 20 minutes on ice. The cell homogenate was then centrifuged at 1000 x g for 10 minutes. The resulting supernatant was then subjected to a 10,000 x g spin for 10 minutes. To obtain the microsomes for proteinase K protection assay and cysteine derivitization, the supernatant from the 10,000 x g spin was centrifuged at 100,000 x g for 1 hour. The resulting pellet was used for subsequent experiments.
Proteinase K protection assay -Membrane vesicles were treated with proteinase K (500 μg/ml) in the presence or absence of 1% (v/v) Triton X-100 for 30 minutes at 4°C. The reaction was then stopped by addition of phenylmethylsulfonyl fluoride at a final concentration of 25 mM. The samples were then boiled for 5 minutes in the presence of sample loading buffer and subjected to immunoblot analysis.
Cysteine derivitization-The procedure for cysteine derivitizaion was based on that described by Feramisco et al. with slight modification (30) . All the buffers used as described below contained protease inhibitors (10 μg/ml leupeptin, 5 μg/ml pepstatin A, 2 μg/ml aprotinin, 2mM PMSF). Membrane vesicle fractions (100,000 x g pellets) were resuspended in buffer B (Buffer A with 100 mM NaCl) with or without 5 mM MTSET and were then incubated at room temperature for 30 minutes. The membranes were then washed and resuspended in 100 μM biotin maleimide. After a 30-minute incubation at room temperature, the reaction was quenched with 10 mM β-mercaptoethanol. The membranes were pelleted and resuspended in buffer C (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1.5% (w/v) Nonidet P-40, 0.1% (w/v) SDS. Each sample then received an aliquot of Immobilized Neutravidin biotin binding protein and was incubated overnight. The sample was then centrifuged to pellet the beads. Biotinylated proteins were released from the bead pellet through boiling and the eluted proteins were analyzed using SDS-PAGE and immunoblotting.
Immunoblot analysis -Protein samples were loaded and separated on a 10% SDS-PAGE, after which the proteins were transferred to Immobilon-P transfer membranes at 4°C. The membranes were than subjected to immunoblot analysis and the antibodies were used at the following concentrations: anti-myc at a dilution of 1:1000; anti-HA at the concentration of 100 ng/ml; anti-KDEL at the concentration of 4 μg/ml; anti-mouse IgG at 1:6000 and anti-rat IgG at 1:15000. Visualization of the bound antibodies was performed using the Super Signal West Pico kit (Pierce). Proteins were quantified using Bradford assay with bovine serum albumin as the standard.
RESULTS
Analysis of the primary sequence of mouse stearoyl-CoA desaturase 1 predicts the presence of four transmembrane domain. Figure 1A shows the distribution of the hydrophobic amino acids of SCD1 using the Kyte-Doolittle hydropathy scale with a window size of 19. The analysis of the network-based algorithm TMHMM (31) also predicted that SCD1 contains four transmembrane domains between amino acids 67-89, 99-121, 213-232, 247-269 with both the N-and C-termini facing the cytosol. This prediction is consistent with the topology model proposed by Stukey et al. based on primary sequence analysis of desaturases (27) .
Expression and functional analysis of the epitope-tagged SCD1 constructs. To map the topology of SCD1, we designed five SCD1 constructs by inserting epitopes at the termini and the predicted loops. To locate the N-and C-termini, we employed two SCD1 constructs with either a HA tag attached to the Nterminus of SCD1 (N-HA-SCD1) or a myc epitope appended to the C-terminus (SCD1-Cmyc). For determining the orientation of the three putative loops, we generated three SCD1 constructs in pcDNA 3.1 vector with a myc epitope at the C-terminus and a HA epitope in each loop ( Figure 1B) . We inserted the HA epitope after amino acid 93 in the first ER lumenal loop (93HA-C-myc), amino acid 138 in the cytosolic loop (138HA-C-myc), and amino acid 241 in the second ER lumenal loop (241HA-C-myc).
The epitope-tagged constructs were transiently expressed in HeLa cells for 48 hours and the cells were harvested for analysis. SCD1 protein of the expected molecular weight (~41kDa) was produced by all constructs ( Figure  2A ). To determine if the insertion of epitope would have deleterious effect on the folding of the protein into its final three-dimensional structure, SCD activity assays were also performed on microsomes isolated from the transfected cells. The basal level of SCD activity in HeLa cells transfected with empty pcDNA3.1 vector was almost undetectable. The SCD activity of N-HA-SCD1 and SCD1-C-myc was higher than the basal level by 23-folds and 39-folds, respectively, whereas those of 93HA-C-myc and 138HA-C-myc were significantly (5.5-and 5.9-folds, respectively) higher than that of the empty vector transfected cells, indicating that the constructs were functional ( Figure 2B ). The lower SCD activity in the case of 93HA-C-myc and 138HA-C-myc was clearly due to a lower expression level of the constructs compared to their terminally tagged counterparts (Figure 2A ). In order to give an apparent level of activity especially for the constructs 93HA-C-myc and 138HA-C-myc, we normalized the SCD activity values in figure 2B to the corresponding expression level of the recombinant constructs ( Figure  2C ). Unfortunately, insertion of the HA epitope after amino acid 241 resulted in a nonfunctional protein that could not be employed in the subsequent indirect immunofluorescence studies. Insertion of epitope has been shown to result in non-functional proteins in other topology study (32, 33) , and it is assumed to be due to misfolding or differences in the conformational state of the recombinant protein compared to the wild-type protein.
The epitopes at N-and C-termini and amino acid 138 are oriented to the cytosol whereas the epitope at residue 93 is located in the ER lumen. The approach of inserting epitopes in the internal hydrophilic loops has been employed in the analysis of the topology of various polytopic membrane proteins (34) (35) (36) (37) . Topology data obtained from full-length functional constructs are considered reliable (34) . With the constructs N-HA-SCD1, SCD1-C-myc, 93HA-C-myc and 138HA-C-myc being functional, we proceeded to determine the orientation of the N-and C-termini as well as the loops by locating the epitopes using indirect cytoimmunofluorescence. We employed indirect cytoimmunofluorescence with selective membrane permeabilization in which the cells were selectively disrupted with 0.3% Triton X-100 or digitonin at a concentration of 3 μg/ml. Incubation with Triton X-100 results in permeabilization of the plasma membrane and the ER, whereas digitonin only disrupts the plasma membrane and leaves the ER intact. In order to evaluate whether the semi-permeabilization was satisfactory, we performed indirect cytoimmunofluorescence using monoclonal antibody that identifies binding protein/glucoseregulated protein of 78kDa (BiP/Grp78), the lumenal ER marker that carries the KDEL sequence. Figure 3A shows a representative result that BiP/Grp78 was visible and displayed the characteristic reticular pattern for ER protein when the cells were treated with 0.3% Triton X-100. However, under permeabilization with digitonin (3μg/ml), the reticular pattern was absent implying that ER membrane remained intact so that the antiBip/Grp78 antibody was not able to interact with the antigen (Fig 3B) . As an additional control, we transfected HeLa cells with the FLAGglycosylphosphatidylinositol 8 (FLAG-GPI8) construct which has the FLAG epitope appended to the N-terminus of the protein that is oriented towards the ER lumen (38) . Similar cytoimmunofluorescence results were obtained as in the case of the endogenous BiP/Grp78 ( Figure  3C-D) .
We then transiently transfected HeLa cells with SCD1-C-myc, N-HA-SCD1, 93HA-C-myc and 138HA-C-myc for 24 hours and performed indirect cytoimmunofluorescence as described above. Both SCD1-C-myc and N-HA-SCD1 showed an equally clear ER staining pattern under both digitonin and Triton X-100 permeabilization ( Figures 3E-H) . This observation implied that the anti-myc and anti-HA antibodies had full access to their targets under both the semi-and complete permeabilization conditions. Therefore, we concluded that both the N-and C-termini of the SCD1 protein are oriented towards the cytosol.
The HA epitope introduced after amino acid 93 was visible only in the Triton X-100 treated cells but not in the digitonin semi-permeabilized cells, demonstrating an ER lumenal orientation ( Figure 3I-J) . As for the mutant 138HA-C-myc, the HA epitope was visible in both complete permeabilized and semi-permeabilized cells indicating a cytosolic orientation (Figure 3K-L) . Taken together, the N-and C-termini of SCD1 are oriented towards the cytosol. The loop between the first and second TMDs (93HA) is oriented towards the ER lumen whereas the loop between the second and third TMDs (138HA) faces the cytosol.
The loop between the third and fourth TMDs is oriented towards the ER lumen. As stated above, the insertion of the HA tag after amino acid 241 produced a protein that was non-functional, suggesting a possible failure to attain the proper three-dimensional structure.
Accordingly, we employed other methods to determine the topology of this region, which corresponds to the predicted third and fourth transmembrane domains as well as the hydrophilic loop connecting them. It is generally believed that the first hydrophobic signal in a polytopic protein, which is usually the first hydrophobic segment, directs the insertion of the protein into the endoplasmic reticulum. However, it has also been shown that other transmembrane domains in a multispanning protein also contain information that targets the protein to the membrane (39) . This argument has also been observed in the investigation of fatty acid transport protein (FATP) topology (34) . To confirm that this region of SCD1 is membrane-associated as predicted, we generated a construct (EGFP-206-272) with the fragment of SCD1 expressing amino acids 206-272 cloned into an EGFP-C2 vector. If the fusion of GFP to this protein fragment results in the targeting of the otherwise cytosolic GFP to the membrane, it would suggest that this protein sequence is membrane-associated. demonstrates a membrane-associated staining pattern that is clearly distinct from the cytosolic distribution of EGFP alone ( Figure 4E and F) . The result shows that this region is membraneassociated.
The data from the GFP chimera experiment together with the prediction of the protein topology based on the hydropathy analysis of SCD1 sequence suggest that this hydrophobic region is associated with the ER membrane. To establish the orientation of the linker loop, cysteine derivitization was employed. One of the major advantages of this approach is the minimal perturbation of the protein structure through single amino acid cysteine mutation. The mouse SCD1 contains five cysteine residues at the amino residues 92, 97, 222, 233 and 322 ( Figure 1B) . According to the predicted topology of SCD1, cysteine 233 is located at the second lumenal loop connecting the third and fourth TMDs. Therefore, we prepared a construct (233C) expressing the mutated SCD1 protein where all but the cysteine at residue 233 were mutated to serines with a myc epitope appended to the C-terminus.
The construct was transfected into HeLa cells and was tested for expression and functionality. Figure 5A shows that the 233C mutant gave a clear ER meshlike network pattern when transfected into HeLa cells indicating the correct targeting of the mutant protein. Figure 5B shows that the construct was functional, showing an approximately 5 foldincrease in activity compared to the cells transfected with the empty pcDNA vector. The lower SCD activity per mg of total protein shown here as compared to that of the constructs with single cysteine substitution ( Figure 6B ) is due to the lower expression level of the 233C construct.
To determine the orientation of the cysteine in the 233C construct, we performed cysteine derivitization. Membrane vesicles were prepared from HeLa cells transfected with the construct 233C by differential centrifugation. Proteinase K protection assay was performed to confirm that the vesicles were intact and right-side-out, i.e. ER lumen stays inside ( Figure 5C ). Bip/Grp78, a protein known to be located in the ER lumen, was employed for visualization. In the absence of Triton X-100, Bip/Grp78 was resistant to proteinase K digestion. However, when the vesicles were incubated with Triton X-100, Bip/Grp78 was destroyed by proteinase K. These results confirm that the vesicles were sealed and were in the correct orientation.
The vesicles were incubated with or without the membrane impermeable thiol reactive agent, MTSET, followed by treatment with a membrane permeable cysteine derivitization reagent, biotinylated maleimide.
After the second derivitization treatment, the membranes were solubilized with Nonidet P-40 detergent. Neutravidin beads were then added to precipitate the biotinylated proteins.
The precipitated proteins were then separated by 10% SDS-PAGE and immunoblotted with anti-myc antibody (30) . We would expect the result to be of one of the following scenarios: 1) if the loop is oriented towards the cytosol, the mutated protein would not be biotinylated in the presence of MTSET and therefore would not be detected. 2) If the loop is facing the ER lumen, the cysteine on the mutated protein would be biotinylated whether it is previously exposed to MTSET or not and would be detected on the western blot. 3) If the postulated loop is actually located within the lipid bilayer, biotinylation would not take place since the reaction would only take place in the water phase. Figure 5D shows the result of the cysteine derivitization. In the absence of MTSET, the mutated SCD1 was biotinylated and was detected by anti-myc antibody as expected. However, in the presence of MTSET, the SCD1 protein was also biotinylated suggesting that the loop between the third and the fourth TMDs is oriented towards the ER lumen.
The conserved cysteines in the mouse SCD1 protein are not essential for the enzyme activity. It has been suggested that SCD might be a thiol enzyme since the addition of phydroxymercuribenzoate, a thiol reactive compound, at a very low concentration was able to inhibit the enzyme activity (28) . However, this inhibition could be rescued by the addition of a thiol compound such as mercaptoethanol (28) . Sequence analysis of the rat SCD1, the human SCD and the four isoforms of mouse SCD shows the presence of several cysteine residues, with the number varying from three to seven. Among these cysteine residues, only the ones present at positions 222-226 and 322-327 are conserved. With reference to mouse SCD1, the conserved cysteines are at position 222 and 322. According to our proposed topology model, cysteine 222 is buried in the lipid bilayer, whereas cysteine 322 is located in the cytosol. Given the topology of SCD and the speculation that SCD might be a thiol enzyme, it is interesting to ask whether the cysteines are catalytically essential, specifically, the cytosolic cysteine 322. We mutated each of the 5 cysteines in SCD1 to serine, and tested the functionality and expression of the five constructs (C92S, C97S, C222S, C233S, C322S). Figure 6A shows the expression of the different constructs and figure 6B shows the activity of the different cysteine-mutated constructs compared to the wildtype enzyme. The SCD activity of the mutants was comparable to that of the wild-type, suggesting that none of the cysteines are significantly important for the enzyme activity. The lower activity in the case of C222S was due to a lower expression of the recombinant protein as shown in figure 6A . DISCUSSION SCD has been shown to play a crucial role in the regulation of lipid metabolism (1), and understanding the three dimensional structure of the protein will aid in elucidating the molecular mechanism of the desaturation process. Unfortunately, highresolution structural information for this protein has not been available to date. Advances in bioinformatics have allowed us to predict the topology of membrane proteins by analysis of the primary amino acid sequence. However, very often, different algorithms produce different predictions (40) (41) (42) . In this study, we studied the topology of mouse SCD1 with a combination of methods including transfecting epitope-tagged full length SCD into HeLa cells and determining the location of the epitopes by immunofluorescence and cysteine derivitization experiments. Topology of many polytopic membrane proteins in the plasma membrane (36, 43) , mitochondria (35) and ER (37, 44) have been delineated by employing the epitope tagging strategy in which the epitopes are usually appended at the termini and the putative loops. In the case of SCD1, all the constructs were functional except for the one where the epitope was introduced in the second lumenal loop. Similar intolerance of the insertion of epitope was also reported in studies on the topology of other membrane proteins such as FATP and glycerol-3-phosphate acyltransferase (GPAT) (34, 35) . It was speculated that the modified loop might prevent the protein from folding into the correct conformation (35) . Since the second ER lumenal loop in SCD1 seemed to be sensitive to the epitope tag insertion, we tried to determine the orientation of this loop by cysteine derivitization where the perturbation to the overall protein structure was minimized. Fusion of the amino acid sequence corresponding to the third and fourth TMDs to EGFP resulted in the targeting of the otherwise cytosolic EGFP to the membrane, confirming that this region of SCD1 is membrane-associated. Based on our results from cytoimmunofluorescence analysis and cysteine derivitization assay, we propose that SCD1 contains four transmembrane domains connected by three hydrophilic loops with the N-and Ctermini oriented towards the cytosol, as depicted in figure 7 . The two ER luminal loops are relatively small, consisting of about 9 to 15 amino acids in contrast to the cytosolic loop of about 100 amino acids, which houses two of the three conserved histidine motifs (HRLWSH, HRAHH). The last histidine motif (HNYHH) is located on the Cterminal arm of the protein. The conserved histidine residues are essential for the desaturase activity and have been proposed to serve as ligands for the iron atom, thus forming the catalytic site (6) .
Based on our proposed topology of SCD1, four of the five cysteine residues are on the lumenal side of the ER membrane and thus likely would not play a catalytic role. However, it was suggested that SCD is a sulfhydryl-sensitive enzyme (49, 50) .
Holloway et al. provided evidence that p-hydroxymercuribenzoate was able to inhibit the desaturase activity (28) . This observation invited speculation that the thiol group in cysteines might be required in the formation of an acyl-S-enzyme before desaturation took place and be important for the overall stabilization of the protein (28) . Moreover, cysteine scanning mutagenesis study on muscle carnitine palmitoyltransferase I, which also utilizes acylCoAs as substrate, has revealed that a single cysteine is important for catalysis, probably serving as the site for the covalent attachment of the acyl-CoAs (51) . In addition to that, Reiser and Raju (49) have also provided evidence that the inhibition of the desaturase by cyclopropene fatty acyl-CoAs is due to the irreversible binding of the sulfhydryl groups of the enzyme by the cyclopropene group. Treatment of the desaturation system with compounds containing reactive thiol prevents the inhibition (49) . However, similar thiol protection from inhibition was not observed in other studies (52) . Sequence analysis of the rat SCD1, the human SCD and the four isoforms of mouse SCD shows the presence of several cysteine residues (ranging from 3 to 7) and among these, two were conserved. Since there is a controversy over the catalytic significance of cysteines in the desaturase, we carried out mutagenesis study to confirm whether cysteines in SCD are catalytically essential, especially C322, one of the two conserved cysteines that is located in the C-terminal cytosolic arm close to the third histidine motif. However, our findings from the mutation studies have revealed that the cysteine residues are not critical in SCD function.
Our proposed topology is consistent with other findings on the structural aspects of SCD. SCD is the terminal enzyme in the desaturase system which involves NADH-cytochrome b 5 reductase and cytochrome b 5 (5-7). Studies have shown that the NADH-cytochrome b 5 reductase and cytochrome b 5 are localized on the cytoplasmic side of the ER (45) . Given the fact that these two proteins serve to transfer electrons to the terminal desaturase, it is logical to deduce that the active site of the desaturase would be exposed to the cytosol (46). Prasad et al. showed that exposure of intact chicken liver microsomes to trypsin as well as to the anti-chicken desaturase antibody inhibited the activity of the chicken delta-9 desaturase, suggesting that the active site of the enzyme is localized on the cytoplasmic surface of the ER (46) . It is noteworthy that the chicken delta-9 desaturase shares a 60% amino acid homology with the mouse counterpart, implying a high possibility that the two proteins would have a similar overall conformation. In our current study, the epitope tag inserted after amino acid 138 in the mouse SCD1 is oriented in the cytosol. This insertion is between the first two conserved histidine motifs which span from residues 116-121 and 153-157, thus strongly supporting the finding of Prasad et al. that the iron-containing active site as defined by the three conserved histidine motifs is facing the cytosol. SCD belongs to the family of the integral membrane desaturases which is comprised of acylCoA and acyl-lipid desaturases. The substrates for acyl-CoA desaturase are fatty acids that are esterified to CoA, whereas acyl-lipid desaturase introduces a double bond into the acyl-chain of membrane glycerolipids. Based on the topology model proposed by Diaz et al., the Bacillus subtilis acyl-lipid Δ5 desaturase (delta-5-Des), contains six TMDs and one membrane-associatead domain (25) . Similar to many other membrane bound desaturases, delta-5-Des also contains a tripartite motif of histidine residues essential for enzyme catalysis. However, the hydropathy analysis of other membrane-associated desaturases that utilize acyl-CoAs as substrates, such as acyl-CoA Δ9 desaturase in yeast (27) and mammalian cells (47), murine and human Δ6 desaturase (48) predict only 4 TMDs, versus the 6 TMDs in the model proposed by Diaz et al. (25) . It is therefore interesting to speculate that the topology of desaturases may be correlated to the substrates utilized, i.e. desaturases that utilize acyl-CoAs as substrates tend to contain 4 TMDs whereas desaturases that desaturate fatty acids esterified to glycerolipids contain more than 4 TMDs. In fact, Diaz et al. hypothesized that the additional TMDs in the acyl-lipid desaturase, which were lacking in the acyl-CoA desaturases, might serve to stabilize the enzyme during the desaturation of the acylchains of membrane glycerolipids (25) .
In conclusion, our topology study has established the foundation for further structurefunction studies on SCD. As stated previously, the four mouse SCD isoforms share a high degree of amino acid homology. Recently, we have found that the different isoforms have different substrate specificities (unpublished data), and evaluation of the regions responsible for this could be guided by our model. Apart from this, previous studies from our lab have shown that endogenously synthesized oleate or palmitoleate, which arise from SCD activity in the endoplasmic reticulum, may be better substrates for acyl-CoA cholesterol acyltransferase (ACAT), glycerol-3-phosphate acyltransferase (GPAT) and acyl-CoA diacylglycerol acyltransferase (DGAT) in the synthesis of cholesteryl esters and triglycerides (53) . Because SCD, ACAT, GPAT and DGAT are ER membrane enzymes, it is tempting to hypothesize that SCD is located within the vicinity of other lipogenic enzymes to produce a more readily accessible substrate to aid in the efficient esterification of cholesterol, glycerol-3-phophate, and diacylglycerol for cholesteryl ester and triglyceride synthesis. With the topology of ACAT (37), GPAT (35) , and SCD being available, it will be interesting to investigate if there are any candidate regions for possible protein-protein interactions.
Further structure-function investigations would help to elucidate the specific role of SCD in lipid metabolism. phosphate acyltransferase; ACAT, acyl-CoA cholesterol acyltransferase; DGAT, acyl-CoA diacylglycerol acyltransferase FIGURE LEGENDS Figure 1 Hydropathy plot of the mouse SCD1 amino acid sequence and the design of the epitopetagged SCD1 constructs (A) Hydropathy plot of mouse SCD1. A window of 19 amino acids was used for the generation of the Kyte-Doolittle plot of SCD1. The hydrophobic residues are shown above zero whereas the hydrophilic residues below zero. The four predicted TMDs are labeled as I, II, III, and IV. (B) Design of the epitope-tagged SCD1 constructs. The figure shows the four predicted transmembrane domains I-IV (rectangular block). HA epitope (diamond) was appended to the N-terminus (N-HA-SCD1). A myc epitope (flag) was added to the C-terminus (SCD1-C-myc). HA epitope tags were also inserted at the predicted hydrophilic loops after amino acids 93 (93HA-C-myc), 138 (138HA-C-myc) or 241 (241HA-C-myc) and a myc epitope was appended to the C-termini of these 3 constructs. Filled circles represent the 5 cysteines at residues 92, 97, 222, 233, and 322. The conserved histidine motifs that are proposed to form the catalytic site are shown as filled ovals. HeLa cells were transiently transfected with N-HA-SCD1, SCD1-myc-C, 93HA, 138HA or FLAG-GPI8 and were allowed to grow on cover slips. 24 hours after transfection, the cells were fixed with 4% paraformaldehyde and were treated with 3% Triton X-100 to completely permeabilize the membranes (A, C, E, G, I, and K) or incubated with digitonin (3μg/μl) (B, D, F, H, J, and L) to disrupt the plasma membrane only. The permeabilized cells were then stained with the corresponding antibodies. Red fluorescent images represent the visualization of KDEL, FLAG epitope and myc epitope whereas green fluorescent images represent the staining pattern of HA epitope. Anti-KDEL antibody was used to detect the endogenous ER lumenal protein BiP/Grp78, which contains the KDEL sequence (A and B) whereas anti-FLAG monoclonal antibody was used to probe for the FLAG epitope on the N-terminus of GPI-8 (FLAG-GPI8), which is oriented towards the ER lumen (C and D). Inaccessibility of the anti-KDEL and anti-FLAG antibodies to their antigens shows that the ER membrane remained intact during incubation with digitonin. Anti-myc monoclonal antibody was used to detect the myc epitope at the C-terminus of SCD1-myc-C (E and F). Anti-HA monoclonal antibodies were used to probe for the HA epitope in cells transfected with N-HA-SCD1 (G and H), 93HA-C-myc (I and J), 138HA-C-myc (K and L). The bound primary antibodies were visualized with the corresponding Alexa-Fluor 488 or Alexa-Fluor 594 conjugated secondary antibodies. Figure 4 Immunofluorescence analysis of EGFP-SCD1 fusion constructs expressed in HeLa cells. HeLa cells were transiently transfected with the following constructs: 1) empty EGFP vector, 2) EGFP-SCD1, which encodes the full length SCD1 protein fused to the C-terminus of EGFP or 3) EGFP-206-272, which expresses the predicted membrane associated region of SCD1 that corresponds to the putative third and fourth TMDs fused to the C-terminus of EGFP. 24 hours after transfection, the expression of the EGFP or the fusion EGFP was examined by immunofluorescence microscopy. (C) The vesicles were treated with proteinase K in the presence or absence of triton X-100 as a control to test the integrity and orientation of the vesicles. Bip/Grp78, an ER lumenal protein, was employed for visualization. (D) Localization of the cysteine at residue 233 as determined by MTSET derivitization. Membrane fractions prepared from HeLa cells transfected with the construct 233C were incubated with or without the membrane impermeable thiol reactive agent, MTSET, followed by treatment with a membrane permeable cysteine derivitization reagent, biotinylated maleimide. After the second derivitization treatment, the membranes were washed and solubilized with Nonidet P-40 detergent. Neutravidin beads were then added to precipitate the biotinylated proteins. The precipitated proteins were then separated by 10% SDS-PAGE and probed with anti-myc antibody. Ponceau S staining of the total proteins serves as the loading control. Figure 6 . Expression and functional analysis of the SCD1 constructs with single cysteine to serine mutation (A) Immunoblot analysis of the microsomes prepared from HeLa cells transiently transfected with cysteine-mutated constructs, C92S, C97S, C222S, C233S, C322S, wild-type SCD1 and empty pcDNA3.1 vector. Ponceau S staining of the total proteins serves as the loading control. Anti-myc monoclonal antibody was used to probe for the myc epitope appended to the C-terminus of the SCD1 constructs. (B) SCD activity of the mutated constructs was assayed as described in Experimental procedures. The slightly lower activity of C222S was due to the lower expression of the recombinant protein as shown in figure 6A . Data are averages ± S.E. (n=3) Figure 7 . Proposed model for the membrane topology of mouse stearoyl-CoA desaturase 1. This model shows that SCD1 contains 4 transmembrane domains (represented by the numbers 1-4) with both the N-and C-termini oriented towards the cytosol. The two ER lumenal loops are relatively small compared to the cytosolic loop which houses two of the three conserved histidine motifs. The highlighted residues represented the conserved histidine regions which are catalytically essential. N and C represent amino-and carboxyl termini, respectively. 93, 138 represent the amino acids after which the HA epitopes were inserted internally. The five cysteines in SCD1 are located at residues 92, 97, 222, 233, and 322. 206 and 272 are the amino acid cut-off points when designing the recombinant construct EGFP 206-272 which expresses the sequence corresponding to TMDs 3 and 4 and the connecting loop. ER, endoplasmic reticulum. Table 1 . Primers used for synthesizing SCD1 constructs with internal HA epitope. Bolded sequence represents HA epitope and underlined sequence encodes myc epitope.
Constructs
Fragment A Fragment B 93HA-C-myc 
